Skip to main content
Erschienen in: Supportive Care in Cancer 4/2007

01.04.2007 | Original Article

The prognostic association of health-related quality of life scores with survival in breast cancer

verfasst von: Digant Gupta, Joel Granick, James F. Grutsch, Christopher G. Lis

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

There is extensive data showing that health-related quality of life (HRQOL) tools measuring the activities of daily life provide prognostic information in cancer. However, similar information on HRQOL tools measuring patient satisfaction with their life is sparse. The Ferrans and Powers quality of life index (QLI) is one such instrument. This study evaluated the association between HRQOL, as measured by the QLI, and survival in breast cancer.

Materials and methods

We examined a consecutive case series of 251 histologically confirmed breast cancer patients treated at Cancer Treatment Centers of America® between April 2001 and November 2004. QLI measures overall HRQOL and the HRQOL in four major subscales: health and physical functioning, social and economic, psychological and spiritual, and family. All scores range from 0 to 30 with higher scores indicating a better HRQOL. Study patients were dichotomized into two groups based on the median scores for all QLI subscales. Kaplan–Meier method was used to calculate survival. Log-rank test was used to study the equality of survival distributions. Multivariate Cox regression analyses were then performed to evaluate the joint prognostic significance of HRQOL and clinical factors.

Results

Patient satisfaction with health and physical subscale was significantly associated with survival (p = 0.0006), with the median survival for low and high scores being 17.8 and 35.3 months, respectively. Similarly, patient satisfaction with overall HRQOL was significantly associated with survival (p = 0.0006), with the median survival for low and high scores being 17.8 and 34.6 months, respectively. Patient satisfaction with health and physical subscale and overall HRQOL were found to be predictive of survival independent of the effects of stage at presentation.

Conclusions

This study suggests that baseline patient satisfaction with health and physical functioning and overall HRQOL, as measured by QLI, provides useful prognostic information in patients with breast cancer independent of stage at presentation.
Literatur
1.
Zurück zum Zitat Blazeby JM, Brookes ST, Alderson D (2000) Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 87(3):362–373CrossRef Blazeby JM, Brookes ST, Alderson D (2000) Prognostic value of quality of life scores in patients with oesophageal cancer. Br J Surg 87(3):362–373CrossRef
2.
Zurück zum Zitat Coates A, Gebski V, Signorini D et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10(12):1833–1838PubMed Coates A, Gebski V, Signorini D et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol 10(12):1833–1838PubMed
3.
Zurück zum Zitat Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33(7):1025–1030PubMedCrossRef Coates A, Porzsolt F, Osoba D (1997) Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33(7):1025–1030PubMedCrossRef
4.
Zurück zum Zitat Coates AS, Hurny C, Peterson HF et al (2000) Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18(22):3768–3774PubMed Coates AS, Hurny C, Peterson HF et al (2000) Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 18(22):3768–3774PubMed
5.
Zurück zum Zitat Collette L, van Andel G, Bottomley A et al (2004) Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 22(19):3877–3885PubMedCrossRef Collette L, van Andel G, Bottomley A et al (2004) Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol 22(19):3877–3885PubMedCrossRef
6.
Zurück zum Zitat Dancey J, Zee B, Osoba D et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 6(2):151–158PubMedCrossRef Dancey J, Zee B, Osoba D et al (1997) Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res 6(2):151–158PubMedCrossRef
7.
Zurück zum Zitat Dharma-Wardene M, Au HJ, Hanson J et al (2004) Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13(7):1209–1216PubMedCrossRef Dharma-Wardene M, Au HJ, Hanson J et al (2004) Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13(7):1209–1216PubMedCrossRef
8.
Zurück zum Zitat Earlam S, Glover C, Fordy C et al (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14(1):171–175PubMed Earlam S, Glover C, Fordy C et al (1996) Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 14(1):171–175PubMed
9.
Zurück zum Zitat Efficace F, Biganzoli L, Piccart M et al (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40(7):1021–1030PubMedCrossRef Efficace F, Biganzoli L, Piccart M et al (2004) Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40(7):1021–1030PubMedCrossRef
10.
Zurück zum Zitat Fang FM, Liu YT, Tang Y et al (2004) Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100(2):425–432PubMedCrossRef Fang FM, Liu YT, Tang Y et al (2004) Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100(2):425–432PubMedCrossRef
11.
Zurück zum Zitat Fang FM, Tsai WL, Chiu HC et al (2004) Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58(5):1394–1404PubMedCrossRef Fang FM, Tsai WL, Chiu HC et al (2004) Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 58(5):1394–1404PubMedCrossRef
12.
Zurück zum Zitat Herndon JE, Fleishman S, Kornblith AB et al (1999) Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 85(2):333–340PubMedCrossRef Herndon JE, Fleishman S, Kornblith AB et al (1999) Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 85(2):333–340PubMedCrossRef
13.
Zurück zum Zitat Kramer JA, Curran D, Piccart M et al (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36(12):1498–1506PubMedCrossRef Kramer JA, Curran D, Piccart M et al (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36(12):1498–1506PubMedCrossRef
14.
Zurück zum Zitat Langendijk H, Aaronson NK, de Jong JM et al (2000) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55(1):19–25PubMedCrossRef Langendijk H, Aaronson NK, de Jong JM et al (2000) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55(1):19–25PubMedCrossRef
15.
Zurück zum Zitat Luoma ML, Hakamies-Blomqvist L, Sjostrom J et al (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39(10):1370–1376PubMedCrossRef Luoma ML, Hakamies-Blomqvist L, Sjostrom J et al (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39(10):1370–1376PubMedCrossRef
16.
Zurück zum Zitat Maisey NR, Norman A, Watson M et al (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38(10):1351–1357PubMedCrossRef Maisey NR, Norman A, Watson M et al (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38(10):1351–1357PubMedCrossRef
17.
Zurück zum Zitat Montazeri A, Milroy R, Hole D et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31(2–3):233–240PubMedCrossRef Montazeri A, Milroy R, Hole D et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31(2–3):233–240PubMedCrossRef
18.
Zurück zum Zitat Roychowdhury DF, Hayden A, Liepa AM (2003) Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 21(4):673–678PubMedCrossRef Roychowdhury DF, Hayden A, Liepa AM (2003) Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 21(4):673–678PubMedCrossRef
19.
Zurück zum Zitat Tamburini M, Brunelli C, Rosso S, Ventafridda V (1996) Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 11(1):32–41PubMedCrossRef Tamburini M, Brunelli C, Rosso S, Ventafridda V (1996) Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 11(1):32–41PubMedCrossRef
20.
Zurück zum Zitat Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed
21.
Zurück zum Zitat Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed
22.
Zurück zum Zitat Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed
23.
Zurück zum Zitat Ferrans CE, Powers MJ (1992) Psychometric assessment of the Quality of Life Index. Res Nurs Health 15(1):29–38PubMedCrossRef Ferrans CE, Powers MJ (1992) Psychometric assessment of the Quality of Life Index. Res Nurs Health 15(1):29–38PubMedCrossRef
24.
Zurück zum Zitat Lis CG, Gupta D, Granick J (2006) Can patient satisfaction with quality of life predict survival in advanced colorectal cancer. Support Care Cancer (in press) Lis CG, Gupta D, Granick J (2006) Can patient satisfaction with quality of life predict survival in advanced colorectal cancer. Support Care Cancer (in press)
Metadaten
Titel
The prognostic association of health-related quality of life scores with survival in breast cancer
verfasst von
Digant Gupta
Joel Granick
James F. Grutsch
Christopher G. Lis
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0165-z

Weitere Artikel der Ausgabe 4/2007

Supportive Care in Cancer 4/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.